Several studies have reported the potential of PPAR ligands to preserve functional beta cell mass in obesity models and in clinical type 2 diabetes [38], [39], but only a limited number of reports has characterized the role of LXRs in this context [25], [26]. This evidence concerns the gene PPARA and type 2 diabetes mellitus.